Advances in Construction and Application of Biliary Organoids

Zhongwen LEI; Yang XIANG; Yijun YANG

doi:10.3881/j.issn.1000-503X.16367

PDF(1364 KB)

Acta Academiae Medicinae Sinicae ›› 2025, Vol. 47 ›› Issue (4) : 611-620. DOI: 10.3881/j.issn.1000-503X.16367

Review Articles

Advances in Construction and Application of Biliary Organoids

Author information +

History +

Abstract

Biliary duct injury,congenital biliary atresia,biliary tract tumors,primary sclerosing cholangitis,etc.are common and refractory diseases in the digestive system in clinical practice.The existing surgical operations and drug treatments demonstrate limited effects.Organoids,as an emerging technology,have attracted much attention in recent years for deeply understanding the pathogenesis and development of these diseases and seeking more effective treatment approaches.An organoid,a three-dimensional complex derived from stem/progenitor cells,can simulate the complex structure and physiological function of tissues or organs in vitro.It provides an important platform for studying the pathogenesis of biliary tract diseases and brings new hope for the repair and regeneration of biliary tract injury.The seed cells for constructing biliary organoids are mainly biliary tract epithelial cells,pluripotent stem cells,etc.The conventional technologies for constructing biliary organoids mainly include embedding,rotary culture,and hanging drop culture.In recent years,new culture technologies such as organ chip and three-dimensional and four-dimensional printing are emerging.This article reviews the construction methods of biliary organoids,discusses the application of these organoids in disease model construction,disease mechanism research,drug screening,and tissue/organ repair,and proposes the current problems and future research directions of biliary organoids,which will provide reference for treating common refractory digestive system diseases in clinical practice.

Key words

organoid / biliary tract disease / drug screening / regenerative medicine

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Zhongwen LEI , Yang XIANG , Yijun YANG. Advances in Construction and Application of Biliary Organoids[J]. Acta Academiae Medicinae Sinicae. 2025, 47(4): 611-620 https://doi.org/10.3881/j.issn.1000-503X.16367

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

[1]	De’angelis N, Catena F, Memeo R, et al. 2020 WSES guidelines for the detection and management of bile duct injury during cholecystectomy[J]. World J Emerg Surg,2021, 16(1):30.DOI:10.1186/s13017-021-00369-w. Cited in this article [1]

[2]	Marino MV, Mirabella A, Guarrasi D, et al. Robotic-assisted repair of iatrogenic common bile duct injury after laparoscopic cholecystectomy:surgical technique and outcomes[J]. Int J Med Robot, 2019, 15(3):e1992.DOI:10.1002/rcs.1992. Cited in this article [1]

[3]	Guerra F, Coletta D, Gavioli M, et al. Minimally invasive surgery for the management of major bile duct injury due to cholecystectomy[J]. J Hepatobiliary Pancreat Sci, 2020, 27(4):157-163.DOI:10.1002/jhbp.710. Cited in this article [1]

[4]	Licata JP, Schwab KH, Har-El YE, et al. Bioreactor technologies for enhanced organoid culture[J]. Int J Mol Sci, 2023, 24(14):11427.DOI:10.3390/ijms241411427. Cited in this article [1]

[5]	O’connell L, Winter DC. Organoids:past learning and future directions[J]. Stem Cells Dev, 2020, 29(5):281-289.DOI:10.1089/scd.2019.0227. Cited in this article [1]

[6]	Ogoke O, Maloy M, Parashurama N. The science and engineering of stem cell-derived organoids-examples from hepatic,biliary,and pancreatic tissues[J]. Biol Rev Camb Philos Soc, 2021, 96(1):179-204.DOI:10.1111/brv.12650. Cited in this article [1]

[7]	Sato K, Zhang W, Safarikia S, et al. Organoids and spheroids as models for studying cholestatic liver injury and cholangiocarcinoma[J]. Hepatology, 2021, 74(1):491-502.DOI:10.1002/hep.31653. Cited in this article [1]

[8]	Sampaziotis F, Muraro D, Tysoe OC, et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver[J]. Science, 2021, 371(6531):839-846.DOI:10.1126/science.aaz6964. Cited in this article [3]

[9]	Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche[J]. Nature, 2009, 459(7244):262-265.DOI:10.1038/nature07935. Cited in this article [1]

[10]	Li Y, Zeng PM, Wu J, et al. Advances and applications of brain organoids[J]. Neurosci Bull, 2023, 39(11):1703-1716.DOI:10.1007/s12264-023-01065-2. Cited in this article [1]

[11]	Matkovic Leko I, Schneider RT, Thimraj TA, et al. A distal lung organoid model to study interstitial lung disease,viral infection and human lung development[J]. Nat Protoc, 2023, 18(7):2283-2312.DOI:10.1038/s41596-023-00827-6. Cited in this article [1]

[12]	Nishinakamura R. Advances and challenges toward developing kidney organoids for clinical applications[J]. Cell Stem Cell, 2023, 30(8):1017-1027.DOI:10.1016/j.stem.2023.07.011. Cited in this article [1]

[13]	Beshiri M, Agarwal S, Yin JJ, et al. Prostate organoids:emerging experimental tools for translational research[J]. J Clin Invest, 2023, 133(10):e169616.DOI:10.1172/jci169616. Cited in this article [1]

[14]	Liu S, Fang C, Zhong C, et al. Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity[J]. Cell Biol Toxicol, 2023, 39(6):2527-2549.DOI:10.1007/s10565-023-09835-4. Cited in this article [1]

[15]	Wu F, Wu D, Ren Y, et al. Generation of hepatobiliary organoids from human induced pluripotent stem cells[J]. J Hepatol, 2019, 70(6):1145-1158.DOI:10.1016/j.jhep.2018.12.028. Cited in this article [1]

[16]	Wang S, Wang X, Tan Z, et al. Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury[J]. Cell Res, 2019, 29(12):1009-1026.DOI:10.1038/s41422-019-0242-8. Cited in this article [1]

[17]	Sampaziotis F, Tysoe O, Brevini T, et al. Use of biliary organoids in cholestasis research[J]. Methods Mol Biol, 2019,1981:373-382.DOI:10.1007/978-1-4939-9420-5_25. Cited in this article [1]

[18]	Habanjar O, Diab-Assaf M, Caldefie-Chezet F, et al. 3D cell culture systems:tumor application,advantages,and disadvantages[J]. Int J Mol Sci, 2021, 22(22):12200.DOI:10.3390/ijms222212200. Cited in this article [1]

[19]	Lee SY, Teng Y, Son M, et al. Three-dimensional aggregated spheroid model of hepatocellular carcinoma using a 96-pillar/Well plate[J]. Molecules, 2021, 26(16):4949.DOI:10.3390/molecules26164949. Cited in this article [1]

[20]	Mattei C, Lim R, Drury H, et al. Generation of vestibular tissue-like organoids from human pluripotent stem cells using the rotary cell culture system[J]. Front Cell Dev Biol, 2019,7:25.DOI:10.3389/fcell.2019.00025. Cited in this article [1]

[21]	Ryu NE, Lee SH, Park H. Spheroid culture system methods and applications for mesenchymal stem cells[J]. Cells, 2019, 8(12):1620.DOI:10.3390/cells8121620. Cited in this article [2]

[22]	Sun B, Zhao Y, Wu W, et al. A superhydrophobic chip integrated with an array of medium reservoirs for long-term hanging drop spheroid culture[J]. Acta Biomater, 2021, 135:234-242.DOI:10.1016/j.actbio.2021.08.006. Cited in this article [1]

[23]	Zhou S, Yang J, Li R, et al. Live imaging of 3D hanging drop arrays through manipulation of light-responsive pyroelectric slippery surface and chip adhesion[J]. Nano Lett, 2023, 23(23):10710-10718.DOI:10.1021/acs.nanolett.3c02570. Cited in this article [1]

[24]	Marques IA, Fernandes C, Tavares NT, et al. Magnetic-based human tissue 3D cell culture:a systematic review[J]. Int J Mol Sci, 2022, 23(20):12681.DOI:10.3390/ijms232012681. Cited in this article [1]

[25]	Tepe U, Aslanbay Guler B, Imamoglu E. Applications and sensory utilizations of magnetic levitation in 3D cell culture for tissue engineering[J]. Mol Biol Rep, 2023, 50(8):7017-7025.DOI:10.1007/s11033-023-08585-0. Cited in this article [1]

[26]	Xing C, Kemas A, Mickols E, et al. The choice of ultra-low attachment plates impacts primary human and primary canine hepatocyte spheroid formation,phenotypes,and function[J]. Biotechnol J, 2024, 19(2):e2300587.DOI:10.1002/biot.202300587. Cited in this article [1]

[27]	Hockney S, Parker J, Turner JE, et al. Next generation organoid engineering to replace animals in cancer drug testing[J]. Biochem Pharmacol, 2023,213:115586.DOI:10.1016/j.bcp.2023.115586. Cited in this article [1]

[28]	Deng S, Li C, Cao J, et al. Organ-on-a-chip meets artificial intelligence in drug evaluation[J]. Theranostics, 2023, 13(13):4526-4558.DOI:10.7150/thno.87266. Cited in this article [1]

[29]	Li X, Zhu H, Gu B, et al. Advancing intelligent organ-on-a-chip systems with comprehensive in situ bioanalysis[J]. Adv Mater, 2023, 36(18):e2305268.DOI:10.1002/adma.202305268. Cited in this article [1]

[30]	Nasiri R, Zhu Y, De Barros NR.Microfluidics and organ-on-a-chip for disease modeling and drug screening[J]. Biosensors(Basel), 2024, 14(2):86.DOI:10.3390/bios14020086. Cited in this article [1]

[31]	Palasantzas V, Tamargo-Rubio I, Le K, et al. IPSC-derived organ-on-a-chip models for personalized human genetics and pharmacogenomics studies[J]. Trends Genet, 2023, 39(4):268-284.DOI:10.1016/j.tig.2023.01.002. Cited in this article [1]

[32]	Baptista LS, Porrini C, S Kronemberger G, et al. Corrigendum:3D organ-on-a-chip:the convergence of microphysiological systems and organoids[J]. Front Cell Dev Biol, 2024,12:1365671.DOI:10.3389/fcell.2024.1365671. Cited in this article [1]

[33]	Shoji JY, Davis RP, Mummery CL, et al. Global meta-analysis of organoid and organ-on-chip research[J]. Adv Healthc Mater, 2023, 13(21):e2301067.DOI:10.1002/adhm.202301067. Cited in this article [1]

[34]	Kantaros A. 3D printing in regenerative medicine:technologies and resources utilized[J]. Int J Mol Sci, 2022, 23(23):14621.DOI:10.3390/ijms232314621. Cited in this article [1]

[35]	Assad H, Assad A, Kumar A. Recent developments in 3D bio-printing and its biomedical applications[J]. Pharmaceutics, 2023, 15(1):255.DOI:10.3390/pharmaceutics15010255. Cited in this article [1]

[36]	Jing S, Lian L, Hou Y, et al. Advances in volumetric bioprinting[J]. Biofabrication, 2023, 16(1):012004.DOI:10.1088/1758-5090/ad0978. Cited in this article [1]

[37]	Mandal A, Chatterjee K. 4D printing for biomedical applications[J]. J Mater Chem B, 2024, 12(12):2985-3005.DOI:10.1039/d4tb00006d. Cited in this article [1]

[38]	Kalogeropoulou M, Díaz-Payno PJ, Mirzaali MJ, et al. 4D printed shape-shifting biomaterials for tissue engineering and regenerative medicine applications[J]. Biofabrication, 2024, 16(2):022002.DOI:10.1088/1758-5090/ad1e6f. Cited in this article [1]

[39]	Wan X, Xiao Z, Tian Y, et al. Recent advances in 4D printing of advanced materials and structures for functional applications[J]. Adv Mater, 2024, 36(34):e2312263.DOI:10.1002/adma.202312263. Cited in this article [1]

[40]	Marsee A, Roos FJM, Verstegen MMA, et al. Building consensus on definition and nomenclature of hepatic,pancreatic,and biliary organoids[J]. Cell Stem Cell, 2021, 28(5):816-832.DOI:10.1016/j.stem.2021.04.005. Cited in this article [1]

[41]	Lugli N, Kamileri I, Keogh A, et al. R-spondin 1 and noggin facilitate expansion of resident stem cells from non-damaged gallbladders[J]. EMBO Rep, 2016, 17(5):769-779.DOI:10.15252/embr.201642169. Cited in this article [1]

[42]	Sampaziotis F, Justin AW, Tysoe OC, et al. Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids[J]. Nat Med, 2017, 23(8):954-963.DOI:10.1038/nm.4360. Cited in this article [2]

[43]	Verstegen MMA, Roos FJM, Burka K, et al. Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease[J]. Sci Rep, 2020, 10(1):21900.DOI:10.1038/s41598-020-79082-8. Cited in this article [1]

[44]	Zhu JJ, Yang YF, Dong R, et al. Biliatresone:progress in biliary atresia study[J]. World J Pediatr, 2023, 19(5):417-424.DOI:10.1007/s12519-022-00619-0. Cited in this article [1]

[45]	Glessner JT, Ningappa MB, Ngo KA, et al. Biliary atresia is associated with polygenic susceptibility in ciliogenesis and planar polarity effector genes[J]. J Hepatol, 2023, 79(6):1385-1395.DOI:10.1016/j.jhep.2023.07.039. Cited in this article [1]

[46]	Short C, Zhong A, Xu J, et al. TWEAK/FN14 promotes profibrogenic pathway activation in Prominin-1-expressing hepatic progenitor cells in biliary atresia[J]. Hepatology, 2023, 77(5):1639-1653.DOI:10.1097/hep.0000000000000026. Cited in this article [1]

[47]	Deng YH, Pu CL, Li YC, et al. Analysis of biliary epithelial-mesenchymal transition in portal tract fibrogenesis in biliary atresia[J]. Dig Dis Sci, 2011, 56(3):731-740.DOI:10.1007/s10620-010-1347-6. Cited in this article [1]

[48]	Lendahl U, Lui VCH, Chung PHY, et al. Biliary atresia-emerging diagnostic and therapy opportunities[J]. EBioMedicine, 2021,74:103689.DOI:10.1016/j.ebiom.2021.103689. Cited in this article [1]

[49]	Chen S, Li P, Wang Y, et al. Rotavirus infection and cytopathogenesis in human biliary organoids potentially recapitulate biliary atresia development[J]. mBio, 2020, 11(4):e01968-20.DOI:10.1128/mBio.01968-20. Cited in this article [1]

[50]	Amarachintha SP, Mourya R, Ayabe H, et al. Biliary organoids uncover delayed epithelial development and barrier function in biliary atresia[J]. Hepatology, 2022, 75(1):89-103.DOI:10.1002/hep.32107. Cited in this article [5]

[51]	Xing J, Ding P, Wan X, et al. Application and progress of cultured models of gallbladder carcinoma[J]. J Clin Transl Hepatol, 2023, 11(3):695-704.DOI:10.14218/jcth.2022.00351. Cited in this article [1]

[52]	Domènech Omella J, Cortesi EE, Verbinnen I, et al. A novel mouse model of combined hepatocellular-cholangiocarcinoma induced by diethylnitrosamine and loss of ppp2r5d[J]. Cancers(Basel), 2023, 15(16):4193.DOI:10.3390/cancers15164193. Cited in this article [1]

[53]	Calvisi DF, Boulter L, Vaquero J, et al. Criteria for preclinical models of cholangiocarcinoma:scientific and medical relevance[J]. Nat Rev Gastroenterol Hepatol, 2023, 20(7):462-480.DOI:10.1038/s41575-022-00739-y. Cited in this article [1]

[54]	Nuciforo S, Heim MH. Organoids to model liver disease[J]. JHEP Rep, 2021, 3(1):100198.DOI:10.1016/j.jhepr.2020.100198. Cited in this article [1]

[55]	Zhou G, Lieshout R, Van Tienderen GS, et al. Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells[J]. Br J Cancer, 2022, 127(4):649-660.DOI:10.1038/s41416-022-01839-x. Cited in this article [1]

[56]	Maier CF, Zhu L, Nanduri LK, et al. Patient-derived organoids of cholangiocarcinoma[J]. Int J Mol Sci, 2021, 22(16):8675.DOI:10.3390/ijms22168675. Cited in this article [1]

[57]	Reich M, Spomer L, Klindt C, et al. Downregulation of TGR5(GPBAR1)in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis[J]. J Hepatol, 2021, 75(3):634-646.DOI:10.1016/j.jhep.2021.03.029. Cited in this article [1]

[58]	Zhang W, Kyritsi K, Isidan A, et al. Development of scaffold-free three-dimensional cholangiocyte organoids to study the progression of primary sclerosing cholangitis[J]. Am J Pathol, 2023, 193(9):1156-1169.DOI:10.1016/j.ajpath.2023.05.005. Cited in this article [1]

[59]	Du Y, De Jong IEM, Gupta K, et al. Human vascularized bile duct-on-a chip:a multi-cellular micro-physiological system for studying cholestatic liver disease[J]. Biofabrication, 2023, 16(1):015004.DOI:10.1088/1758-5090/ad0261. Cited in this article [1]

[60]	Jalan-Sakrikar N, De Assuncao TM, Navarro-Corcuera A, et al. Induced pluripotent stem cells from subjects with primary sclerosing cholangitis develop a senescence phenotype following biliary differentiation[J]. Hepatol Commun, 2022, 6(2):345-360.DOI:10.1002/hep4.1809. Cited in this article [2]

[61]	Yang R, Yu Y. Patient-derived organoids in translational oncology and drug screening[J]. Cancer Lett, 2023,562:216180.DOI:10.1016/j.canlet.2023.216180. Cited in this article [1]

[62]	Magré L, Verstegen MMA, Buschow S, et al. Emerging organoid-immune co-culture models for cancer research:from oncoimmunology to personalized immunotherapies[J]. J Immunother Cancer, 2023, 11(5):e006290.DOI:10.1136/jitc-2022-006290. Cited in this article [1]

[63]	Yuan B, Zhao X, Wang X, et al. Patient-derived organoids for personalized gallbladder cancer modelling and drug screening[J]. Clin Transl Med, 2022, 12(1):e678.DOI:10.1002/ctm2.678. Cited in this article [1]

[64]	Ren X, Huang M, Weng W, et al. Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application[J]. Cell Rep Med, 2023, 4(11):101277.DOI:10.1016/j.xcrm.2023.101277. Cited in this article [1]

[65]	Xiang Y, Wang W, Gao Y, et al. Production and characterization of an integrated multi-layer 3D printed PLGA/GelMA scaffold aimed for bile duct restoration and detection[J]. Front Bioeng Biotechnol, 2020,8:971.DOI:10.3389/fbioe.2020.00971. Cited in this article [1]

[66]	Hu W, Lazar MA. Modelling metabolic diseases and drug response using stem cells and organoids[J]. Nat Rev Endocrinol, 2022, 18(12):744-759.DOI:10.1038/s41574-022-00733-z. Cited in this article [1]

[67]	Hu Y, Hu X, Luo J, et al. Liver organoid culture methods[J]. Cell Biosci, 2023, 13(1):197.DOI:10.1186/s13578-023-01136-x. Cited in this article [1]

[68]	Du Y, Khandekar G, Llewellyn J, et al. A bile duct-on-a-chip with organ-level functions[J]. Hepatology, 2020, 71(4):1350-1363.DOI:10.1002/hep.30918. Cited in this article [1]

[69]	Monteduro AG, Rizzato S, Caragnano G, et al. Organs-on-chips technologies-aguide from disease models to opportunities for drug development[J]. Biosens Bioelectron, 2023,231:115271.DOI:10.1016/j.bios.2023.115271. Cited in this article [1]

[70]	Charles S, Jackson-Holmes E, Sun G, et al. Non-invasive quality control of organoid cultures using mesofluidic CSTR bioreactors and high-content imaging[J]. Adv Mater Technol, 2024, 10(3):2400473.DOI:10.1002/admt.202400473. Cited in this article [1]

[71]	Fang S, Todd PW, Hanley TR. A bench-scale rotating bioreactor with improved oxygen transfer and cell growth[J]. Chem Eng Sci, 2022,256:117688.DOI:10.1016/j.ces.2022.117688. Cited in this article [1]

[72]	Rimal R, Muduli S, Desai P, et al. Vascularized 3D human skin models in the forefront of dermatological research[J]. Adv Healthc Mater, 2024, 13(9):e2303351.DOI:10.1002/adhm.202303351. Cited in this article [1]

[73]	Ock SA, Kim SY, Ju WS, et al. Adipose tissue-derived mesenchymal stem cells extend the lifespan and enhance liver function in hepatocyte organoids[J]. Int J Mol Sci, 2023, 24(20):15429.DOI:10.3390/ijms242015429. Cited in this article [1]